Caspase-11 Controls Interleukin-1Β Release Through Degradation of TRPC1.

Benedicte F. Py,Mingzhi Jin,Bimal N. Desai,Anirudh Penumaka,Hong Zhu,Maike Kober,Alexander Dietrich,Marta M. Lipinski,Thomas Henry,David E. Clapham,Junying Yuan
DOI: https://doi.org/10.1016/j.celrep.2014.02.015
IF: 8.8
2014-01-01
Cell Reports
Abstract:Caspase-11 is a highly inducible caspase that controls both inflammatory responses and cell death. Caspase-11 controls interleukin 1β (IL-1β) secretion by potentiating caspase-1 activation and induces caspase-1-independent pyroptosis downstream of noncanonical NLRP3 inflammasome activators such as lipopolysaccharide (LPS) and Gram-negative bacteria. However, we still know very little about the downstream mechanism of caspase-11 in regulating inflammation because the known substrates of caspase-11 are only other caspases. Here, we identify the cationic channel subunit transient receptor potential channel 1 (TRPC1) as a substrate of caspase-11. TRPC1 deficiency increases the secretion of IL-1β without modulating caspase-1 cleavage or cell death in cultured macrophages. Consistently, trpc1(-/-) mice show higher IL-1β secretion in the sepsis model of intraperitoneal LPS injection. Altogether, our data suggest that caspase-11 modulates the cationic channel composition of the cell and thus regulates the unconventional secretion pathway in a manner independent of caspase-1.
What problem does this paper attempt to address?